Integrated Kidney Care of Central California, LLC
KCE Located In: Central California
Participant Groups and Providers
THE NEPHROLOGY GROUP INC
ADELA AYALA
AMARINDER GARCHA
ANURADHA SURI
ATULKUMAR ROY
CAROL ROSS MCCORMICK
DANIEL IKEMIYASHIRO
DENNIS REDUBLA
DOMINIQUE DORSAINVIL
GREGORY MARTINEZ
HARMEET GURM
HARPREET DHINDSA
HASHIM KAZMI
HEMANT DHINGRA
HOMER PUNSALAN
JASJIT SINGH
JOSEPH DUFLOT
LANIGAIL PANGILINAN
MANJOT DHALIWAL
MEI-TSUEY HWANG
MELESSA MATTIS
MELISA ARREGUIN
NEYSHA SANCHEZ RIVERA
NISHKARSH SAXENA
PANKAJ RAM
PETER MCCAULEY
PREETI PAL
RAHUL BHARDWAJ
ROBERTO PARDO
SAMATHHA REDDY
SLAMAT ALI
SREEDHAR ADAPA
STEPHANIE DAVILA-GOMEZ
STEVE SU
STEVEN LEVY
SUDHIR JOSHI
SUKHVIR ATWAL
WEI-TZUOH CHEN
YANGMING CAO
Preferred Groups and Providers
VILLAGEHEALTH DM LLC
Governing Body Designees
Clinical and Administrative Leadership
Kerri Green
Primary Contact & Administrative Leader
Director, DaVita IKC
Jasjit Singh
KCE Clinical Leader
The Nephrology Group
Quality Measures
Information for the following performance measures will be available by February 1st, 2024.
- The Depression Response measure is a patient-reported outcome measure that assesses the percentage of adult patients (18 years of age or older) who score >9 on the Patient Health Questionnaire (PHQ-9), have a diagnosis of major depression or dysthymia and who demonstrate a response to treatment at approximately 12 months.
- The Patient Activation Measure (PAM) licensed through Insignia Health (a Phreesia company), assesses the attitudes, motivators, and behaviors that allow a patient to manage his or her healthcare issues. Patient activation is essential to achieving improved health outcomes and cost control.
- Optimal ESRD Starts quantifies the ability of healthcare providers to prepare patients for ESRD by educating them and their families about the need for dialysis or kidney transplant, helping them to make appropriate and informed choices about their treatment modality, and supporting them in successfully transitioning to dialysis or kidney transplantation as kidney function declines.
Shared Savings and Losses
Information for the following performance measures will be available by February 1st, 2024.
- Total amount of Shared Savings or Shared Losses per Performance Year
- Proportion of Shared Savings invested in the program and other resources necessary to improve outcomes and reduce Medicare costs for Beneficiaries
- Proportion of Shared Savings to KCE Participants and Preferred Providers for each Performance Year
For a full list of facilities and joint ventures, please click here.
For more information on CKCC, click here.